Current Projects

                       asian lab tech blue pms2945  green peti dish  lab2 pink pms213  doctors conf green pms374  conf overhead purple pms2593

20 Active Projects at 17 Institutions in 15 Diseases

Diabetes Massachusetts General Hospital Dr. Faustman Repurposing a Vaccine for Type I Diabetes Drug Adult In Process
Diabetic Ophthalmology Northwestern University Dr. Basti Treating Cataracts in Diabetic Patients Using a Surgical Device Device Adult Started 2018
GI Boston Children's Hospital Dr. Kahn Fecal Microbiota Transplantation Patient Registry for Pediatric C-diff Other Pediatric In Process
GI OpenBiome, University of Cape Town Drs. Osman, Budree The THRIVE Study: Repurposing Fecal Microbiota Transplantation for the Treatment of Pediatric Malnutrition in South Africa* Other Pediatric Started 2019
Inner Ear Curtin University Dr. Brown Testing a generic diuretic to improve drug delivery to the inner ear in Ménière’s disease Drug Pre-clinical Started 2020
Inner Ear Hospital of the Ludwig-Maximilians University, Munich Dr. Strupp Combining a vertigo drug with a Parkinson’s disease drug to treat the inner ear disorder, Ménière’s disease Drug Adult Started 2019
Inner Ear Dent Neurologic Institute Dr. Zhang Combining an anti-epileptic drug  with an anti-anxiety drug to treat the inner ear disorder Ménière’s disease Drug Adult Started 2019
Neuro Johns Hopkins Medicine Dr. Kaplin, Wang Repurposing Over the Counter Cough Medicine as a Rapid Acting Antidepressant Drug Adult Started 2019
Neuro The Pennsylvania State University and the Milton S. Hershey Medical Center Dr. Elfar Repurposing a Multiple Sclerosis Drug in Severe Limb Trauma* Drug into Diagnostic Adult Started 2018
Neuro University of Pennsylvania Medicine Dr. Oathes  Using Imaging Techniques to Guide Targeted Brain Stimulation in the Treatment of Depression and Post-Traumatic Stress Disorder  Device  Adult   In Process
Neuro/Rare  Georgetown University  Dr. Anderson Using a Cancer Drug in Huntington's Disease  Drug Adult Started 2018
Neuro/Rare McGovern Medical School at The University of Texas Health Science Center at Houston Dr. Furr-Stimming Treating Irritability in Huntington’s Disease with a Repurposed Neurological Drug Drug Adult Started 2019
Oncology The Hospital for Sick Children Dr. Suwwan  Low-Level Laser Therapy to Address Treatment Side Effects in Pediatric Cancer Patients Device Pediatric Started 2018
Oncology University of Chicago Drs. Chmura, Bestvina Innovations in Combination Therapies for Non-Small Cell Lung Cancer  Drug Adult In Process
Oncology/Rare  Massachusetts General Hospital/Harvard Medical School, VUmc Cancer Center Amsterdam Drs. Tannous, Arrillaga-Romany, Kouwenhoven A Novel Combination of Generic Chemotherapy Drugs to Treat Brain Cancer Drug Adult Started 2018
Oncology/Rare University of Michigan Dr. Pettit Using a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer, Myelofibrosis Drug Adult Started 2018
Oncology/Rare University of Michigan Dr. Swiecicki  Repurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer* Drug   Adult Started 2018 
Ophthalmic/Rare University of Michigan Dr. Zacks Testing a Generic Malarial Drug in a Rare Ophthalmic Condition, Retinitis Pigmentosa  Drug Adult Started 2018
Rare   The Hospital for Sick Children, National Institutes of Health Drs. Dowling, Bönnemann TAM4MTM: Tamoxifen Therapy for Myotubular Myopathy Drug  Pediatric In Process 
Rare St. Jude Children’s Research Hospital Dr. Nichols Repurposing a Blood Cancer Drug to Treat an Immune Disorder (HLH) in Children* Drug Pediatric Started 2019


*CureAccelerator Live! winner


Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 27th. Copyright 2018 Cures Within Reach.